- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chronic Obstructive Pulmonary Disease Patients
Total 46650 results
-
Pulmatrix Inc.Quotient ClinicalCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
University of EdinburghThe Dunhill Medical TrustCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Universidade Federal de Sao CarlosCompletedChronic Obstructive Pulmonary Disease (COPD)Brazil
-
Helse Stavanger HFCompletedChronic Obstructive Pulmonary Disease (COPD)Norway
-
Hospital de MataróCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic Obstructive | Chronic Obstructive Pulmonary Disease (COPD)Denmark, Germany, Netherlands, Finland, United Kingdom
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Colombia, Spain, Canada, Slovakia, India, Netherlands, Czech Republic, Hungary
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)Russian Federation, Germany, Denmark, Italy, Canada, Czech Republic, Hungary, India, Slovakia, France, Colombia, Finland, Taiwan, Iceland, Peru
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Taiwan, Korea, Republic of, Japan, India, Hong Kong, Singapore
-
my mhealth LtdPortsmouth Hospitals NHS TrustCompletedChronic Obstructive Pulmonary DiseasesUnited Kingdom
-
Wuhan Union Hospital, ChinaRecruitingAcute Exacerbation of Chronic Obstructive Pulmonary DiseaseChina
-
Aveiro UniversityFundação para a Ciência e a TecnologiaRecruitingAcute Exacerbation of Chronic Obstructive Pulmonary DiseasePortugal
-
AstraZenecaTerminatedChronic Obstructive Pulmonary Disease With (Acute) ExacerbationUnited Kingdom
-
Beaumont HospitalCompletedChronic Obstructive Pulmonary Disease (COPD)Ireland
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Australia, Germany, United Kingdom, China, Philippines, Italy, Chile, Taiwan, Thailand, France, Puerto Rico, Israel, Peru, Colombia, Poland, Brazil, Russian Federation, Romania, Greece
-
Reham Mohammed ElmorshedyCompletedChronic Obstructive Pulmonary Disease(COPD)Egypt
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
University of MilanCompletedChronic Obstructive Pulmonary Disease | Salmeterol Effect Against an Acute Alveolar Fluid Clearance Challenge Secondary to Lung Fluid Overload in COPD Patients | Bronchodilator Agents | SalmeterolItaly
-
University of Nove de JulhoCompletedChronic Obstructive Pulmonary Disease (COPDBrazil
-
Newcastle-upon-Tyne Hospitals NHS TrustAstraZeneca; Newcastle UniversityCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Beijing Chao Yang HospitalCompletedAcute Exacerbation of Chronic Obstructive Pulmonary DiseaseChina
-
AstraZenecaCompletedAcute Exacerbation of Chronic Obstructive Pulmonary DiseaseChina
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)China, Denmark, United States, Australia, Canada, Germany, Netherlands, Poland, Spain, United Kingdom, Korea, Republic of, Philippines, Italy, Argentina, Belgium, Bulgaria, Czechia, Finland, Hungary, India, Japan, Mexico, Norway, Port... and more
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Czechia, Denmark, Hungary, Netherlands, Spain, Korea, Republic of, Argentina, Belgium, Bulgaria, Finland, India, Japan, Mexico, Norway, Sweden, Turkey, Vietnam, Portugal, Puerto Rico
-
Cliniques universitaires Saint-Luc- Université...CompletedSevere Chronic Obstructive Pulmonary DiseaseBelgium
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingChronic Obstructive Pulmonary Disease (COPD)United States
-
Verona Pharma plcCompletedChronic Obstructive Pulmonary Disease Moderate
-
Schön Klinik Berchtesgadener LandResMedCompletedChronic Obstructive Pulmonary Disease SevereGermany
-
Imperial College LondonNational Institute for Health Research, United KingdomCompletedASTHMA | CHRONIC OBSTRUCTIVE PULMONARY DISEASE | HEALTHY SUBJECTSUnited Kingdom
-
Peking University People's HospitalRecruitingAcute Exacerbation of Chronic Obstructive Pulmonary DiseaseChina
-
Henry Ford Health SystemCompletedChronic Obstructive Pulmonary Disease | Exacerbation of Chronic Obstructive Pulmonary DiseaseUnited States
-
Unity Health TorontoRecruitingSmoking Cessation | Chronic Obstructive Pulmonary Disease (COPD)Canada
-
Jie LiBinzhou Medical UniversityCompletedChronic Obstructive Pulmonary Disease With (Acute) ExacerbationChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingChronic Obstructive Pulmonary Disease (COPD)China
-
University of ParmaChiesi Farmaceutici S.p.A.Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseItaly
-
Shanghai Zhongshan HospitalRuijin Hospital; The First Affiliated Hospital of Guangzhou Medical UniversityCompletedChronic Obstructive Pulmonary Disease (COPD)China
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany
-
Nephron Pharmaceuticals CorporationRho, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Augusta UniversityCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Turino, Gerard, M.D.National Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
University of ZurichCompletedChronic Obstructive Pulmonary Disease (COPD)Switzerland
-
SunovionTerminatedChronic Obstructive Pulmonary Disease (COPD)United States
-
University of ZurichNational Center of Cardiology and Internal Medicine named after academician...CompletedChronic Obstructive Pulmonary Disease (COPD)Kyrgyzstan
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Romania, Russian Federation, Slovakia, South Africa, Spain, Sweden, Ukraine, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Southeast University, ChinaCompletedAcute Exacerbation Chronic Obstructive Pulmonary DiseaseChina
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Poland
-
Odense University HospitalRegion of Southern DenmarkCompletedChronic Obstructive Pulmonary Disease (COPD)Denmark
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease, COPDSweden, France, Germany, Hungary, Poland, Canada, Australia, Slovakia, Spain